Inventiva (IVA) Current Assets (2018 - 2025)
Inventiva (IVA) posted quarterly Current Assets of $284.6 million for Q4 2025, up 138.82% year-over-year from $119.2 million in Q4 2024, and down 99.85% quarter-over-quarter from $195.6 billion in Q2 2025.
Inventiva (IVA) Current Assets (2018 - 2025) Analysis & Trends
Inventiva's Current Assets history runs 8 years deep, the most recent figure standing at $284.6 million for Q4 2025.
- In Q4 2025, Current Assets rose 138.82% year-over-year to $284.6 million; the TTM figure through Dec 2025 stood at $284.6 million (up 138.82% YoY), while the FY2025 annual figure was $284.6 million, up 138.82% from the prior year.
- Current Assets for Q4 2025 stood at $284.6 million, down from $195.6 billion in the prior quarter.
- The five-year high for Current Assets was $195.6 billion in Q2 2025, with the low at $2.2 million in Q2 2024.
- The 5-year median for Current Assets is $132.2 million (2021), against an average of $27.6 billion.
- The sharpest annual moves came in 2023 and 2025: Current Assets plunged 99.95% in 2023, then soared 9014717.25% in 2025.
- Inventiva's Current Assets stood at $132.2 million in 2021, then dropped by 17.91% to $108.5 million in 2022, then slumped by 52.23% to $51.8 million in 2023, then surged by 129.82% to $119.2 million in 2024, then surged by 138.82% to $284.6 million in 2025.
- Business Quant data shows IVA's Current Assets at $284.6 million in Q4 2025, $195.6 billion in Q2 2025, and $119.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | 284.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 284.57 Mn |
| Jun 30, 2025 | 195.62 Bn |
| Dec 31, 2024 | 119.16 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Dec 31, 2023 | 51.85 Mn |
| Jun 30, 2023 | 57.03 Mn |
| Dec 31, 2022 | 108.54 Mn |
| Jun 30, 2022 | 106.63 Bn |
| Dec 31, 2021 | 132.22 Mn |
| Jun 30, 2021 | 132.26 Mn |
| Mar 31, 2021 | 151.28 Mn |
| Dec 31, 2020 | 158.57 Mn |
| Jun 30, 2020 | 66.27 Mn |
| Dec 31, 2019 | 54.10 Mn |
| Dec 31, 2018 | 81.76 Mn |